Overexpression of eukaryotic translation initiation factor 5A2 (EIF5A2) correlates with cell aggressiveness and poor survival in gastric cancer

PLoS One. 2015 Mar 20;10(3):e0119229. doi: 10.1371/journal.pone.0119229. eCollection 2015.

Abstract

Eukaryotic translation initiation factor 5A2 (EIF5A2) plays an important role in tumor progression and prognosis evaluation. However, little information is available about its potential role in gastric cancer. This study aimed to investigate the function of EIF5A2 in tumor progression and its potential mechanisms. EIF5A2 expression was measured in human gastric cancer cell lines, the immortalized gastric mucosal epithelial cell line (GES-1) and human gastric cancer tissues and knocked down by RNA interference or upregulated by EIF5A2 plasmid transfection. Cell proliferation, migration and invasion were assessed in vitro. The downstream targets of EIF5A2 were examined by western blotting. EIF5A2 and its potential target metastasis-associated protein 1 (MTA1) expression were examined in 160 pairs of human gastric cancer and adjacent non-tumor specimens using immunohistochemistry (IHC) staining, and its correlation with clinicopathological features and survival was investigated. Knockdown of EIF5A2 or MTA1 caused an apparent suppression of HGC27 cell proliferation, migration and invasion. After knockdown of EIF5A2 in HGC27 cells, E-cadherin levels were upregulated and vimentin, cyclin D1, cyclin D3, C-MYC and MTA1 levels were downregulated. Upregulation of EIF5A2 in MKN45 cells resulted in the converse. IHC results showed a positive correlation between EIF5A2 and MTA1 expression in gastric cancers (P<0.001). Both EIF5A2 and MTA1 overexpression were correlated with pT stage (P=0.018 and P=0.042), pN stage (P=0.037 and P=0.020) and lymphovascular invasion (P=0.016 and P=0.044). EIF5A2 or MTA1 overexpression was significantly associated with poor overall survival and disease-free survival (All P<0.05). Multivariate analyses identified EIF5A2 as an independent predictor for both overall survival (P=0.012) and disease-free survival (P=0.008) in gastric cancer patients. Our findings indicate that EIF5A2 upregulation plays an important oncogenic role in gastric cancer. EIF5A2 may represent a new predictor for poor survival and is a potential therapeutic target for gastric cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cell Line, Tumor
  • Cell Proliferation
  • Disease Progression
  • Eukaryotic Translation Initiation Factor 5A
  • Female
  • Gene Expression*
  • Gene Knockout Techniques
  • Histone Deacetylases / genetics
  • Histone Deacetylases / metabolism
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Peptide Initiation Factors / genetics*
  • Prognosis
  • RNA Interference
  • RNA, Small Interfering / genetics
  • RNA-Binding Proteins / genetics*
  • Repressor Proteins / genetics
  • Repressor Proteins / metabolism
  • Stomach Neoplasms / genetics*
  • Stomach Neoplasms / mortality*
  • Stomach Neoplasms / pathology
  • Trans-Activators
  • Tumor Burden

Substances

  • MTA1 protein, human
  • Peptide Initiation Factors
  • RNA, Small Interfering
  • RNA-Binding Proteins
  • Repressor Proteins
  • Trans-Activators
  • Histone Deacetylases

Grants and funding

This work was supported by grants from the Beijing Municipal Natural Science Foundation (No. 7132209), Hubei Province health and family planning scientific research project (No. WJ2015MB137) and Major science and technology projects in Beijing City (No. D141100000414004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.